Bhowmick, Tanaya; Canton, Rafael; Pea, Federico; Quevedo, Juan; Santerre Henriksen, Anne; Timsit, Jean-François; Kaye, Keith S, Cefepime-enmetazobactam: first approved cefepime-β- lactamase inhibitor combination for multi-drug resistant Enterobacterales, «FUTURE MICROBIOLOGY», in corso di stampa, Online ahead of print, pp. 1 - 10 [articolo]Open Access
Cojutti, Pier Giorgio; Tedeschi, Sara; Zamparini, Eleonora; Fornaro, Giacomo; Zagarrigo, Manuel; De Paolis, Massimiliano; Viale, Pierluigi; Pea, Federico, Could a Reduced Dose of 8 g of Continuous Infusion Fosfomycin Be Considered as Effective as and Safer than a Standard 16 g Dose When Combined with High-Dose Daptomycin in the Treatment of Staphylococcal osteoarticular Infections?, «ANTIBIOTICS», 2025, 14, Article number: 139, pp. 1 - 14 [articolo]Open Access
Gatti, Milo; Pea, Federico, Critical reappraisal of current issues for improving the proper clinical use of the incoming beta-lactam/beta-lactamase inhibitor combinations of tomorrow, «EXPERT REVIEW OF ANTI-INFECTIVE THERAPY», 2025, 10.1080/14787210.2025.2493077, pp. 1 - 37 [articolo]
Gatti, Milo; Rinaldi, Matteo; Laici, Cristiana; Siniscalchi, Antonio; Ambretti, Simone; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico, Highly adsorptive removal of cefiderocol during continuous venovenous hemodiafiltration equipped with oXiris filter in an orthotopic liver transplant recipient having septic shock caused by VIM-producing Klebsiella pneumoniae, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2025, 80, pp. 1153 - 1155 [articolo]
Gatti, Milo; Rinaldi, Matteo; Laici, Cristiana; Bonazzetti, Cecilia; Vizioli, Luca; Ambretti, Simone; Morelli, Maria Cristina; Siniscalchi, Antonio; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico, Impact of attaining an aggressive PK/PD target with continuous infusion beta-lactams on the clinical efficacy of targeted therapy of early post-transplant Gram-negative infections in critically ill OLT recipients. An interim analysis of a 3-year prospective, observational, study, «THE JOURNAL OF INFECTIOUS DISEASES», 2025, 10.1093/infdis/jiaf048, pp. 1 - 11 [articolo]
Marcheggiani Muccioli, Giulio Maria; Zamparini, Eleonora; Fogacci, Alberto; Grechi, Andrea; Pea, Federico; Viale, Pierluigi; Zaffagnini, Stefano, Methicillin-resistant Staphylococcus epidermidis knee prosthetic infection treatment with two-stage revision and fosfomycin–rifampin combination therapy: a case report, «JOURNAL OF MEDICAL CASE REPORTS», 2025, 19, Article number: 55, pp. 1 - 10 [articolo]Open Access
Cojutti, Pier Giorgio; Gatti, Milo; Tedeschi, Sara; Zamparini, Eleonora; Meschiari, Marianna; Danzi, Maria; Menegotto, Giacomo; Cotrufo, Marco; Soavi, Laura; Chiari, Erika; Ripa, Marco; Mazzitelli, Maria; Crapis, Massimo; Cattelan, Annamaria; Parruti, Giustino; Russo, Alessandro; Zammarchi, Lorenzo; Tascini, Carlo; Viale, Pierluigi; Pea, Federico, Usefulness of a hub and spoke TDM-guided expert clinical pharmacological advice program of dalbavancin for optimizing very long-term curative or suppressive treatment of chronic staphylococcal infections, «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2025, 69, Article number: e0183024, pp. 1 - 13 [articolo]Open Access
Gatti, Milo; Rinaldi, Matteo; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico, Usefulness of a TDM-Guided Approach for Optimizing Teicoplanin Exposure in the Treatment of Secondary Bloodstream Infections Caused by Glycopeptide-Susceptible Enterococcus faecium, «MICROORGANISMS», 2025, 10.3390/microorganisms13010162, Article number: 162, pp. 1 - 12 [articolo]Open Access
Conti, Matteo; Giorgi, Beatrice; Barone, Rossella; Gatti, Milo; Cojutti, Pier Giorgio; Pea, Federico, A Sensitive Liquid Chromatography–Tandem Mass Spectrometry Method for Measuring Fosfomycin Concentrations in Human Prostatic Tissue, «PHARMACEUTICS», 2024, 10.3390/pharmaceutics16050681, Article number: 681, pp. 1 - 12 [articolo]Open Access
Cojutti, Pier Giorgio; Pai, Manjunath P; Gatti, Milo; Rinaldi, Matteo; Ambretti, Simone; Viale, Pierluigi; Pea, Federico, An innovative population pharmacokinetic/pharmacodynamic strategy for attaining aggressive joint PK/PD target of continuous infusion ceftazidime/avibactam against KPC- and OXA-48- producing Enterobacterales and preventing resistance development in critically ill patients, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2024, 10.1093/jac/dkae290, Article number: dkae290, pp. 1 - 12 [articolo]
Gatti, Milo; Pea, Federico, Are the pharmacokinetic data of meropenem studied in CSF of a mixed population composed of patients with cerebral infections and patients with extracerebral infections really helpful for clinicians treating CNS infections?, «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2024, 10.1128/aac.01453-24, pp. 1 - 3 [replica/breve intervento]
Cojutti, Pier Giorgio; Pai, Manjunath P.; Tonetti, Tommaso; Siniscalchi, Antonio; Viale, Pierluigi; Pea, Federico, Balancing the scales: achieving the optimal beta-lactam to beta-lactamase inhibitor ratio with continuous infusion piperacillin/tazobactam against extended spectrum beta-lactamase producing
Enterobacterales, «ANTIMICROBIAL AGENTS AND CHEMOTHERAPY», 2024, 68, Article number: e0140423, pp. 1 - 11 [articolo]Open Access
Gatti, Milo; Rinaldi, Matteo; Laici, Cristiana; Ambretti, Simone; Siniscalchi, Antonio; Viale, Pierluigi; Pea, Federico, Biliary pharmacokinetic/pharmacodynamic analysis of continuous infusion meropenem/vaborbactam in a case series of orthotopic liver transplant recipients, «JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY», 2024, 10.1093/jac/dkae261, pp. 1 - 4 [articolo]
Gatti, Milo; Cosentino, Federica; Giannella, Maddalena; Viale, Pierluigi; Pea, Federico, Clinical efficacy of cefiderocol-based regimens in patients affected by carbapenem-resistant Acinetobacter baumannii infections: a systematic review with meta-analysis, «INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS», 2024, 63, Article number: 107047, pp. 1 - 5 [articolo]
Gatti, Milo; Rinaldi, Matteo; Tonetti, Tommaso; Siniscalchi, Antonio; Viale, Pierluigi; Pea, Federico, Comparative Impact of an Optimized PK/PD Target Attainment of Piperacillin-Tazobactam vs. Meropenem on the Trend over Time of SOFA Score and Inflammatory Biomarkers in Critically Ill Patients Receiving Continuous Infusion Monotherapy for Treating Documented Gram-Negative BSIs and/or VAP, «ANTIBIOTICS», 2024, 13, Article number: 296, pp. 1 - 16 [articolo]Open Access
